BRPI0407906A - polimorfos de s-omeprazol - Google Patents

polimorfos de s-omeprazol

Info

Publication number
BRPI0407906A
BRPI0407906A BRPI0407906-0A BRPI0407906A BRPI0407906A BR PI0407906 A BRPI0407906 A BR PI0407906A BR PI0407906 A BRPI0407906 A BR PI0407906A BR PI0407906 A BRPI0407906 A BR PI0407906A
Authority
BR
Brazil
Prior art keywords
omeprazole
polymorphs
relates
polymorphic forms
methoxy
Prior art date
Application number
BRPI0407906-0A
Other languages
English (en)
Inventor
Yatendra Kumar
Mahavir Singh Khanna
Mohan Prasad
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of BRPI0407906A publication Critical patent/BRPI0407906A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"POLIMORFOS DE S-OMEPRAZOL". A invenção se refere a formas polimórficas do enantiómero-S de omeprazol que é o S-5-metoxi-2-¢¢(4metoxi-3,5-dimetil-2piridinil)-metil!sulfinil!-1Hbenzimid azol. A invenção também se refere ao processo de preparação das formas polimórficas. Mas particularmente, se refere à preparação de duas formas polimórficas de S-omeprazol, referida como 'Forma I' e 'Forma II' e composições farmacêuticas que incluem a 'Forma I' e 'Forma II'.
BRPI0407906-0A 2003-02-28 2004-03-01 polimorfos de s-omeprazol BRPI0407906A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN199DE2003 2003-02-28
PCT/IB2004/000535 WO2004076440A1 (en) 2003-02-28 2004-03-01 Polymorphs of s-omeprazole

Publications (1)

Publication Number Publication Date
BRPI0407906A true BRPI0407906A (pt) 2006-02-14

Family

ID=32922926

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407906-0A BRPI0407906A (pt) 2003-02-28 2004-03-01 polimorfos de s-omeprazol

Country Status (9)

Country Link
US (1) US20060247277A1 (pt)
EP (1) EP1606279A1 (pt)
CN (1) CN1777598A (pt)
BR (1) BRPI0407906A (pt)
CA (1) CA2517714A1 (pt)
MX (1) MXPA05009183A (pt)
RU (1) RU2005129513A (pt)
WO (1) WO2004076440A1 (pt)
ZA (1) ZA200507009B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7563812B2 (en) 2005-06-15 2009-07-21 Hetero Drugs Limited Amorphous esomeprazole hydrate
KR20080076924A (ko) * 2005-12-05 2008-08-20 아스트라제네카 아베 에소메프라졸 비-염 형태의 제조를 위한 신규 방법
EP2195309A4 (en) 2007-10-08 2013-04-24 Hetero Drugs Ltd SALT POLYMORPHS OF THE ESOMEPRAZOLE
EP2147918A1 (en) * 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Process for the preparation of S-omeprazole magnesium in a stable form
CN113387929A (zh) * 2021-06-30 2021-09-14 江苏中邦制药有限公司 一种艾司奥美拉唑镁三水合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
US20060247277A1 (en) 2006-11-02
MXPA05009183A (es) 2005-10-20
RU2005129513A (ru) 2006-03-10
CA2517714A1 (en) 2004-09-10
CN1777598A (zh) 2006-05-24
ZA200507009B (en) 2006-04-26
EP1606279A1 (en) 2005-12-21
WO2004076440A1 (en) 2004-09-10

Similar Documents

Publication Publication Date Title
ES2195345T3 (es) Nueva forma de s-omeprazol.
ES2191944T3 (es) Forma cristalina de la sal de sodio de omeprazol.
SE9900274D0 (sv) New compound
EE200100248A (et) Omeprasooli uus kristalne vorm
HUP0201659A2 (hu) Kristályos benzimidazol-vegyület
WO2008102145A3 (en) Process for the preparation of esomeprazole magnesium dihydrate
CO4750654A1 (es) Proceso para la sintesis de un compuesto omeprazol
PE20080007A1 (es) Compuestos derivados de bencimidazolona que tienen actividad en el receptor m1
CL2009000906A1 (es) Compuestos derivados de 4-imidazolil y 4-triazolil de 2-(6-(4-cicloalquilpiperazin-1-il)pirimidin-4-il)-1h-pirazol-3(2h)ona inhibidores de hif-prolil-4-hidroxilasas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de enfermedades cardiovasculares, renales y hematologicas.
MX2017007065A (es) Composiciones que comprenden 2-((1-(2(4-fluorofenil)-2-oxoetil) piperidin-4-il)metil)isoindolin-1-ona para tratar la esquizofrenia.
NO20052474L (no) Amort form av esomeprazolsalter
GEP20125649B (en) Benzimidazole compound crystal
BRPI0519398A2 (pt) compostos de piridina para o tratamento de doenÇas mediadas por prostaglandina
DE60216273D1 (de) Kristalline form von omeprazol
SE9704183D0 (sv) New process
BRPI0407906A (pt) polimorfos de s-omeprazol
DK1748998T3 (da) Ny stereoselektiv syntese af benzimidazolsulfoxider
SE0302382D0 (sv) New salts II
SE0302381D0 (sv) New salts I
MEP37108A (en) Stable polymorph of bifeprunox mesilate (7-[4-([1,1'-biphenyl]-3-yl-metheyl)-1-piperazinyl]-2(3h)-benzoxazolone monomethansulfonate
ATE549316T1 (de) Piperidinderivate als nk3-rezeptorantagonisten
ECSP003736A (es) Procedimiento mejorado para la preparacion de derivados de bencimidazol adecuados como farmacos antiulcerosos, particularmente omeprazol o pantoprazol
UY26420A1 (es) Procedimiento mejorado para la preparación de derivados bencimidazol adecuados como fármacos antiulcerosos, particularmente omeprazol o pantoprazol
MY118724A (en) New crystalline form of omeprazole
Fernando Pascual Henri JM Nouwen, Il discernimento. Leggere i segni della vita quotidiana

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]